Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

EASD: New EASD/ADA Position Paper Shifts Treatment Goals with 7 Key Points Posted: Tuesday, October 09, 2012

A new position statement for treatment of type 2 diabetes treatment focuses on the individual patient rather than a "one number fits all" HbA1c target.

EASD: Once a Year Exenatide Introduced at EASD Posted: Monday, October 08, 2012

Continuous long-term delivery of exenatide with Intarcia's osmotic mini-pump system allows optimal dose selection for improved glycemic control, ensures adherence, and improves patient tolerability.

EASD: Merck's Investigational Once-Weekly DPP-4 Inhibitor Significantly Lowered Blood Sugar in Patients with Type 2 Diabetes Posted: Monday, October 08, 2012

Merck announced Phase IIb data for MK-3102, the company's investigational once-weekly DPP-4 inhibitor in development for the treatment of type 2 diabetes.

L-cysteine a Possible Therapy for Type-2 Diabetes Posted: Tuesday, October 02, 2012

Taking L-cysteine supplements may help patients with type 2 diabetes better control blood sugar levels.

Child Obesity Risks Greater than Thought Posted: Tuesday, October 02, 2012

Children who are obese may have an even higher risk for heart disease, diabetes, and other weight-related diseases later in life than has been thought.

Diabetes Before and During Pregnancy a Growing Problem Posted: Monday, October 01, 2012

The rates of both pre-pregnancy and gestational diabetes have increased since 1980, with greater increases in pre-pregnancy diabetes among black women.

Diabetes Cause Linked to Iron Posted: Monday, October 01, 2012

Researchers at the University of Copenhagen, in conjunction with those at Novo Nordisk A/S, have presented a new concept concerning the cause of diabetes which is linked to iron and how it causes beta cell death.

Corn Helps Type 2 Diabetes, Kidney Complications Posted: Tuesday, September 25, 2012

A purple corn variety found in Chile and Peru has been shown to possess some antidiabetic properties that may prove helpful in type 2 diabetes and associated kidney complications.

Twenty Minutes of Exercise Cuts Diabetes Risk Posted: Tuesday, September 25, 2012

Just 20 minutes of exercise a day can protect kids from diabetes.

Pre-Diabetes Is Treatable to Prevent Diabetes Posted: Monday, September 24, 2012

Preservation of beta-cell function is more closely related to long-term prevention of diabetes than is insulin sensitivity.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.